Associated Papers
SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamics.
Lai D et al.
Brain : a Journal of Neurology, 2025
SLC35A2-Related Brain Disorders: Genetics, Pathophysiology, and Therapeutic Insights.
Risso B et al.
International Journal of Molecular Sciences, 2025
41373710 (PubMed )
Supplement: ijms-26-11560-s001.zip › ijms-4001327-supplementary.xlsx › Foglio1
SLC35A2 loss of function variants affect glycomic signatures, neuronal fate, and network dynamics.
Lai D et al.
Biorxiv : the Preprint Server for Biology, 2024
Neuropathology and epilepsy surgery - 2024 update.
Blümcke I
Free Neuropathology, 2024
Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene.
Barba C et al.
Neurology, 2023
CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy.
Mayo S et al.
International Journal of Molecular Sciences, 2022
Functional analyses of the UDP-galactose transporter SLC35A2 using the binding of bacterial Shiga toxins as a novel activity assay.
Li D et al.
Glycobiology, 2019
Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
Winawer MR et al.
Annals of Neurology, 2018
Select a paper to view details